2021
DOI: 10.1016/j.jconrel.2020.10.030
|View full text |Cite
|
Sign up to set email alerts
|

Serum protein-based nanoparticles for cancer diagnosis and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
85
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 122 publications
(85 citation statements)
references
References 244 publications
0
85
0
Order By: Relevance
“…For example, Abraxane is used in the current cancer therapeutics. The paclitaxel-bound albumin nanocomplex has a diameter of around 130 nm and is one of the best-selling anticancer drugs in the market for breast cancer [ 59 ].…”
Section: Types Of Nanoparticlesmentioning
confidence: 99%
See 4 more Smart Citations
“…For example, Abraxane is used in the current cancer therapeutics. The paclitaxel-bound albumin nanocomplex has a diameter of around 130 nm and is one of the best-selling anticancer drugs in the market for breast cancer [ 59 ].…”
Section: Types Of Nanoparticlesmentioning
confidence: 99%
“…They are often used for small-molecular therapeutic drugs and imaging agents due to their minimal toxicity and immunogenicity, which also make them an excellent candidate for vaccine excipients. Although serum proteins are often used to conjugate therapeutic drugs, imaging probes, and targeting ligands, the random distribution of many amine and carboxyl groups in proteins causes irregularity of conjugation with target ligands [ 59 ]. The general strategies of developing protein-based nanoparticles may include desolvation, emulsification, biomineralization, and covalent/non-covalent interactions.…”
Section: Types Of Nanoparticlesmentioning
confidence: 99%
See 3 more Smart Citations